Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05831995
Title Safety and Effectiveness of ABM-168 in Adults With Advanced Solid Tumors.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors ABM Therapeutics Corporation
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCSF Helen Diller Family Comprehensive Cancer Center RECRUITING San Francisco California 94143 United States Details
Indiana University Simon and Bren Simon Comprehensive Cancer Center RECRUITING Indianapolis Indiana 46202 United States Details
Rutgers Cancer Institute of New Jersey RECRUITING New Brunswick New Jersey 08901 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Next Oncology RECRUITING Irving Texas 75039 United States Details
Huntsman Cancer Institute, University of Utah RECRUITING Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field